Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v10-FR
Language French French
Date Updated 2022-05-19 2022-05-05
Drug Identification Number 02240334 02240334
Brand name TEVA-TRYPTOPHAN TEVA-TRYPTOPHAN
Common or Proper name TRYPTOPHAN 500MG CAPS TRYPTOPHAN 500MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TRYPTOPHAN TRYPTOPHAN
Strength(s) 500MG 500MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2021-09-22 2021-09-22
Estimated end date 2022-05-20 2022-05-10
Actual end date 2022-05-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Item is short-dated and about to expire. Item is short-dated and about to expire.
Health Canada comments